A Study of Vismodegib (GDC-0449) in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma
Clinical trial NCT01160250 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT01160250
- Sponsor
- Genentech, Inc.
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
- Start date
- 2010-07-01
- Primary completion
- 2012-04-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.